000 01613 a2200481 4500
005 20250513120705.0
264 0 _c19970627
008 199706s 0 0 eng d
022 _a0022-2623
024 7 _a10.1021/jm9700880
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOhkawa, S
245 0 0 _a7-Spiroindanyl derivatives of naltrexone and oxymorphone as selective ligands for delta opioid receptors.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cMay 1997
300 _a1720-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnalgesia
650 0 4 _aAnalgesics
650 0 4 _aAnimals
650 0 4 _aBrain
_xmetabolism
650 0 4 _aCell Membrane
_xmetabolism
650 0 4 _aEnkephalin, D-Penicillamine (2,5)-
650 0 4 _aEnkephalins
_xantagonists & inhibitors
650 0 4 _aGuinea Pigs
650 0 4 _aIleum
650 0 4 _aLigands
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred ICR
650 0 4 _aMolecular Structure
650 0 4 _aMuscle, Smooth
_xdrug effects
650 0 4 _aNaltrexone
_xanalogs & derivatives
650 0 4 _aOxymorphone
_xanalogs & derivatives
650 0 4 _aReceptors, Opioid, delta
_xagonists
650 0 4 _aSpiro Compounds
_xchemical synthesis
650 0 4 _aVas Deferens
700 1 _aDiGiacomo, B
700 1 _aLarson, D L
700 1 _aTakemori, A E
700 1 _aPortoghese, P S
773 0 _tJournal of medicinal chemistry
_gvol. 40
_gno. 11
_gp. 1720-5
856 4 0 _uhttps://doi.org/10.1021/jm9700880
_zAvailable from publisher's website
999 _c9152999
_d9152999